West to Host Fourth-Quarter and Full-Year 2025 Conference Call

Rhea-AI Summary

West (NYSE: WST) will release fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 12, 2026, followed by a conference call at 8:00 a.m. Eastern Time. A live webcast, slide presentation and 90-day replay will be available on the company's investor website.

EXTON, Pa., Jan. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 12, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

The live webcast can be accessed by clicking here. To ask questions on the conference call, participants need to register in advance by clicking here. Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the webcast will be available on the Company's website for approximately 90 days after the event.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-fourth-quarter-and-full-year-2025-conference-call-302673246.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West (WST) release Q4 and full-year 2025 results and hold the conference call?

West will release results before the market opens on February 12, 2026, then host a call at 8:00 a.m. ET. According to the company, the live webcast will follow the release and a slide presentation will be posted on its investor website the same day.

How can investors access the West (WST) live webcast for the February 12, 2026 conference call?

Investors can access the live webcast via the company's investor website on the day of the call. According to the company, the webcast link and slide presentation will be available on the investor relations section and a replay will be posted for about 90 days.

How do participants register to ask questions on West's (WST) February 12, 2026 conference call?

Participants must register in advance to ask questions and receive dial-in details and a unique PIN. According to the company, registered telephone participants will get a dial-in number plus a PIN that enables them to ask questions on the live call.

Will West (WST) provide slides and a replay after the February 12, 2026 earnings call?

Yes. A slide presentation will be posted the day of the call and a replay will be available for approximately 90 days. According to the company, both slides and a replay can be accessed in the Investors section of its website.

What time is West's (WST) conference call on February 12, 2026, and where is the time referenced?

The conference call is scheduled for 8:00 a.m. Eastern Time on February 12, 2026. According to the company, the time cited is ET and the call will follow the pre-market release of fourth-quarter and full-year 2025 results.